Topic
eGFR
News
5 Jun 2026
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a…
News
3 Nov 2025
Study finds half of agricultural workers with chronic kidney disease in Tamil Nadu have unknown cause
A recent study published in The Lancet Regional Health Southeast Asia has found that nearly one in every 20 agricultural…